MAPLE GROVE, Minn., Nov. 19, 2019 /PRNewswire/ — ZEISS REVERSE ENGINEERING (ZRE) software offers a new and innovative option to significantly improve the tool correction process. Time-consuming iterations are replaced with actual measured values and proven algorithmic methods to reduce process time by over 50 percent. ZRE guides users through this software process step by step. To simplify the solution further, customers can source both the data collection hardware and software from ZEISS for a complete, integrated reverse engineering solution.
ZRE makes tool correction more efficient because it reduces time-consuming work. Typically, tool manufacturers rely on simulation software and experienced tool and die makers to design and produce molds for plastics, stamping, die casting and forging industries. Multiple iterations of corrections to the tool are usually required before a finished part is accepted. Each iteration is both time consuming and costly. With ZRE, tool and die makers use actual measured values from the first test pieces and algorithmic proven methods for tool corrections.
ZRE shortens tool correction iterations substantially: first, high-precision actual data is captured from the initial test components. ZRE then compares the point cloud or mesh to the part CAD model. A nominal/actual analysis is performed to show part deviation and areas out of tolerance. To correct the areas of concern, the software guides the user to invert the deviated points and transforms them to the CAD surfaces of the mold model. Finally, a new surface is created with the corrected points using reverse engineering and the surface refitted to the original mold CAD model. Using this new model, modifications are made to the tool and another test piece is made. This method may be repeated, but success stories have shown that the number of necessary iterations is reduced by more than half. Simulation software and experienced tool and die makers are still valuable assets in tool design, and ZRE extends tool manufacturers the ability to save money and bring products to the market faster.
ZRE also offers the traditional tools of reverse engineering to build CAD models from finished parts using powerful surface reconstruction functions. Added value is provided with evaluation tools to ensure the model is created within expected accuracy parameters.
For the ZEISS solution, users can generate scanned data of a test piece from multiple sources, including computer tomography, optical sensors or a coordinate measuring machine (CMM).
For more information visit www.zeiss.com/metrology or call 1-800-327-9735.
About ZEISS
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 5.8 billion euros in its four segments Industrial Quality & Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology (status: 30 September 2018).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future far beyond the optics and optoelectronics industries. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership.
With approximately 30,000 employees, ZEISS is active globally in almost 50 countries with around 60 of its own sales and service companies, more than 30 production sites and around 25 development sites. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com
ZEISS Industrial Quality Solutions
ZEISS Industrial Quality Solutions is a leading manufacturer of multidimensional metrology solutions. These include coordinate measuring machines, optical and multisensor systems, microscopy systems for industrial quality assurance as well as metrology software for the automotive, aircraft, mechanical engineering, plastics and medical technology industries. Innovative technologies such as 3D X-ray metrology for quality inspection round off the portfolio. In addition, ZEISS Industrial Quality Solutions offers a broad global spectrum of customer services with ZEISS Quality Excellence Centers close to its customers. The company is headquartered in Oberkochen. Production and development sites outside Germany are located in Minneapolis in the USA, Shanghai, China and Bangalore, India. ZEISS Industrial Quality Solutions is part of the Industrial Quality & Research segment.
View original content to download multimedia:http://www.prnewswire.com/news-releases/cut-tool-correction-process-time-in-half-with-zeiss-reverse-engineering-300961157.html
SOURCE Carl Zeiss Industrial Metrology, LLC
NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…
DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…
Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…
Diarrhea is one of the most common reasons for veterinary visits for dogs and the…
Developing innovative bispecific antibodies for monotherapy and combination with the potential to expand the frontiers…
FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…